Impact of Feedback on the Devolpment of Psychotherapeutic Competencies: a Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mental Disorders
- Sponsor
- Goethe University
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Cognitive Therapy Scale (CTS)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The purpose of the current study is to examine the influence of feedback on psychotherapeutic competency. The present randomized controlled study compares a feedback condition with a non-feedback condition. Therapists in the feedback condition receive feedback after every fourth session. The feedback is given by two trained and independent raters. The raters are licenced and experienced psychotherapists. Therapists in the non-feedback condition receive no feedback during the psychotherapy.
Investigators
Florian Weck
PhD
Goethe University
Eligibility Criteria
Inclusion Criteria
- •Having successfully completed the interim audit
- •Having started to treat ambulant patients
- •Remaining at least 6 month in the ambulance
Exclusion Criteria
- •Inclusion Criteria:
- •Meeting ICD 10 criteria for a mental disorder
- •Informed consent
- •Exclusion Criteria:
- •Currently in psychotherapy
- •Suicidal tendency
- •Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder
- •Clinical diagnosis of personality disorder cluster A (odd disorders) and B (dramatic, emotional or erratic)
Outcomes
Primary Outcomes
Cognitive Therapy Scale (CTS)
Time Frame: participants will be followed for the duration of psychotherapy, an expected average of 20 weeks
external-assessment measure that assesses psychotherapeutic competency during a cognitive therapy session. CTS will be used by two trained raters licensed as psychological psychotherapists.
Secondary Outcomes
- Berner Stundenbögen Version 2000(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Global Assessment of Functioning (GAF)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Supervisory Questionaire (SQ)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Supervisee Levels Questionaire (SLQ-R)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Counseling Self-Estimate Inventory (COSE)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Fear of negative evaluation scale (Skala Angst vor negativer Bewertung; SANB)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Brief Symptom Inventory (BSI)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Beck Depression Inventory II (BDI II)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Beck Anxiety Inventory (BAI)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Client Satisfaction Questionaire (CSQ8)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Health-related quality of life (SF-12)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)
- Helping Alliance Questionaire (HAQ)(participants will be followed for the duration of psychotherapy, an expected average of 20 weeks)